SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-001635
Filing Date
2024-03-22
Accepted
2024-03-22 16:30:19
Documents
13
Period of Report
2024-03-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k.htm   iXBRL 8-K 30891
  Complete submission text file 0001683168-24-001635.txt   205261

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE snoa-20240321.xsd EX-101.SCH 3027
3 XBRL LABEL FILE snoa-20240321_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE snoa-20240321_pre.xml EX-101.PRE 22367
16 EXTRACTED XBRL INSTANCE DOCUMENT sonoma_8k_htm.xml XML 3667
Mailing Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301
Business Address 5445 CONESTOGA COURT, SUITE 150 BOULDER CO 80301 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 24775669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)